Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail

[1]  D. Montefiori,et al.  Neutralization tiers of HIV-1 , 2017, Current opinion in HIV and AIDS.

[2]  R. E. Murphy,et al.  Solution Structure and Membrane Interaction of the Cytoplasmic Tail of HIV-1 gp41 Protein. , 2017, Structure.

[3]  Supratik Das,et al.  Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505. , 2017, Virology.

[4]  W. Koff,et al.  Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes , 2016, Retrovirology.

[5]  D. Burton,et al.  Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability , 2016, Nature Communications.

[6]  G. Debnath,et al.  D-101 HIV-1 neutralizing antibodies induced by native-like envelope trimers , 2016 .

[7]  Hanqin Peng,et al.  Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein , 2015, Science.

[8]  R. Wyatt,et al.  Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design. , 2015, Cell reports.

[9]  J. Bhattacharya,et al.  An Efficiently Cleaved HIV-1 Clade C Env Selectively Binds to Neutralizing Antibodies , 2015, PloS one.

[10]  U. Baxa,et al.  Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env , 2015, Journal of Virology.

[11]  R. Wyatt,et al.  Well-Ordered Trimeric HIV-1 Subtype B and C Soluble Spike Mimetics Generated by Negative Selection Display Native-like Properties , 2015, PLoS pathogens.

[12]  John P. Moore,et al.  Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits , 2014, Retrovirology.

[13]  James C Paulson,et al.  Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. , 2014, Immunity.

[14]  John P. Moore,et al.  Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation , 2013, Proceedings of the National Academy of Sciences.

[15]  J. Mascola,et al.  Robust Neutralizing Antibodies Elicited by HIV-1 JRFL Envelope Glycoprotein Trimers in Nonhuman Primates , 2013, Journal of Virology.

[16]  John P. Moore,et al.  A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies , 2013, PLoS pathogens.

[17]  J. Nagle,et al.  Membrane structure correlates to function of LLP2 on the cytoplasmic tail of HIV-1 gp41 protein. , 2013, Biophysical journal.

[18]  G. S. Kumar,et al.  Characterization of DNA Binding Property of the HIV-1 Host Factor and Tumor Suppressor Protein Integrase Interactor 1 (INI1/hSNF5) , 2013, PloS one.

[19]  T. Sturgeon,et al.  Detailed Topology Mapping Reveals Substantial Exposure of the “Cytoplasmic” C-Terminal Tail (CTT) Sequences in HIV-1 Env Proteins at the Cell Surface , 2013, PloS one.

[20]  Eveline Santos da Silva,et al.  The frantic play of the concealed HIV envelope cytoplasmic tail , 2013, Retrovirology.

[21]  R. Montelaro,et al.  C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic , 2013, The Journal of general virology.

[22]  J. Hoxie,et al.  Loss of a Tyrosine-Dependent Trafficking Motif in the Simian Immunodeficiency Virus Envelope Cytoplasmic Tail Spares Mucosal CD4 Cells but Does Not Prevent Disease Progression , 2012, Journal of Virology.

[23]  R. Desrosiers,et al.  The Tale of the Long Tail: the Cytoplasmic Domain of HIV-1 gp41 , 2012, Journal of Virology.

[24]  J. Binley,et al.  HIV-1 Virus-Like Particles Bearing Pure Env Trimers Expose Neutralizing Epitopes but Occlude Nonneutralizing Epitopes , 2012, Journal of Virology.

[25]  J. Mascola,et al.  HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies. , 2011, AIDS research and human retroviruses.

[26]  E. Freed,et al.  HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. , 2011, Journal of molecular biology.

[27]  T. Sturgeon,et al.  Topology of the C-Terminal Tail of HIV-1 gp41: Differential Exposure of the Kennedy Epitope on Cell and Viral Membranes , 2010, PloS one.

[28]  A. Bartesaghi,et al.  Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure , 2010, PLoS pathogens.

[29]  Rajesh P. Ringe,et al.  Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection , 2010, Retrovirology.

[30]  J. Binley,et al.  Improved Induction of Antibodies against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 gp120 DNA Prime-Protein Boost Vaccination Compared to gp120 Protein-Only Vaccination , 2008, Journal of Virology.

[31]  J. Binley,et al.  A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. , 2007, Virology.

[32]  J. Guatelli,et al.  The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120. , 2006, Virology.

[33]  J. Lifson,et al.  Distribution and three-dimensional structure of AIDS virus envelope spikes , 2006, Nature.

[34]  R. Wyatt,et al.  Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage. , 2005, Virology.

[35]  R. Compans,et al.  Surface Stability and Immunogenicity of the Human Immunodeficiency Virus Envelope Glycoprotein: Role of the Cytoplasmic Domain , 2004, Journal of Virology.

[36]  C. Münk,et al.  The Membrane-Proximal Tyrosine-Based Sorting Signal of Human Immunodeficiency Virus Type 1 gp41 Is Required for Optimal Viral Infectivity , 2004, Journal of Virology.

[37]  S. Sarkar,et al.  Rational Site-Directed Mutations of the LLP-1 and LLP-2 Lentivirus Lytic Peptide Domains in the Intracytoplasmic Tail of Human Immunodeficiency Virus Type 1 gp41 Indicate Common Functions in Cell-Cell Fusion but Distinct Roles in Virion Envelope Incorporation , 2003, Journal of Virology.

[38]  W. Anderson,et al.  Cytoplasmic Tail of Moloney Murine Leukemia Virus Envelope Protein Influences the Conformation of the Extracellular Domain: Implications for Mechanism of Action of the R Peptide , 2003, Journal of Virology.

[39]  J. Kappes,et al.  Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy , 2002, Antimicrobial Agents and Chemotherapy.

[40]  Susan Zolla-Pazner,et al.  Truncation of the Cytoplasmic Domain Induces Exposure of Conserved Regions in the Ectodomain of Human Immunodeficiency Virus Type 1 Envelope Protein , 2002, Journal of Virology.

[41]  J. Haas,et al.  Identification of Two Sequences in the Cytoplasmic Tail of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein That Inhibit Cell Surface Expression , 2001, Journal of Virology.

[42]  D R Burton,et al.  gp120: Biologic aspects of structural features. , 2001, Annual review of immunology.

[43]  C. A. Derdeyn,et al.  Mutational Analysis of Conserved Domains within the Cytoplasmic Tail of gp41 from Human Immunodeficiency Virus Type 1: Effects on Glycoprotein Incorporation and Infectivity , 2000, Journal of Virology.

[44]  E. Buratti,et al.  Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response. , 2000, Virology.

[45]  E. Freed,et al.  The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Benarous,et al.  Interactions of the Cytoplasmic Domains of Human and Simian Retroviral Transmembrane Proteins with Components of the Clathrin Adaptor Complexes Modulate Intracellular and Cell Surface Expression of Envelope Glycoproteins , 1999, Journal of Virology.

[47]  J. Sodroski,et al.  The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.

[48]  M. Mulligan,et al.  Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain , 1994, Journal of virology.

[49]  D. Littman,et al.  Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity , 1993, Journal of virology.

[50]  H. Klenk,et al.  Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60 , 1992, Nature.

[51]  E. Freed,et al.  Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160 , 1989, Journal of virology.

[52]  M. Maksimovic,et al.  Solution , 1902, The Mathematical Gazette.

[53]  D. Burton,et al.  Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge , 2008, Nature Medicine.